Aarkstore - Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) since January 2007.
Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Navidea Biopharmaceuticals, Inc. (formerly Neoprobe Corporation) since January 2007.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Aarkstore</strong> Enterprise<br />
<strong>Aarkstore</strong> - <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>.<br />
(<strong>formerly</strong> <strong>Neoprobe</strong> <strong>Corporation</strong>) - <strong>Mergers</strong> &<br />
<strong>Acquisitions</strong> (M&A), <strong>Partnerships</strong> & <strong>Alliances</strong> <strong>and</strong><br />
<strong>Investment</strong> <strong>Report</strong><br />
Browse Full <strong>Report</strong> @<br />
http://www.aarkstore.com/business-consumer-services/75523/navidea-biopharmaceuticals-inc-<strong>formerly</strong>neoprobe-corporation-mergers-acquisitions-ma-partnerships-alliances-<strong>and</strong>-investment-report<br />
Published: Nov 2014| No. Of Pages: 62 Pages<br />
PDF: $ 350| Enterprise Wide License : $ 875|<br />
Project Synopsis<br />
Company <strong>Mergers</strong> & <strong>Acquisitions</strong> (M&A), <strong>Partnerships</strong> & <strong>Alliances</strong> <strong>and</strong> <strong>Investment</strong>s reports offer a<br />
comprehensive breakdown of the organic <strong>and</strong> inorganic growth activity undertaken by an organization to<br />
sustain its competitive advantage.<br />
Project Description<br />
MarketLines' <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong> <strong>Neoprobe</strong> <strong>Corporation</strong>) <strong>Mergers</strong> & <strong>Acquisitions</strong><br />
(M&A), <strong>Partnerships</strong> & <strong>Alliances</strong> <strong>and</strong> <strong>Investment</strong>s report includes business description, detailed reports on<br />
mergers <strong>and</strong> acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership <strong>and</strong><br />
partnership transactions undertaken by <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong> <strong>Neoprobe</strong> <strong>Corporation</strong>)<br />
since January 2007.<br />
Scope<br />
<br />
Provides intelligence on <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong> <strong>Neoprobe</strong> <strong>Corporation</strong>)'s M&A,<br />
strategic partnerships <strong>and</strong> alliances, capital raising <strong>and</strong> private equity transactions.
<strong>Aarkstore</strong> Enterprise<br />
<br />
<br />
<br />
Detailed reports of various financial transactions undertaken by <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>.<br />
(<strong>formerly</strong> <strong>Neoprobe</strong> <strong>Corporation</strong>) <strong>and</strong> its subsidiaries since 2007.<br />
Information about key financial <strong>and</strong> legal advisors for <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong><br />
<strong>Neoprobe</strong> <strong>Corporation</strong>)'s financial deals transactions.<br />
Financial deals tables <strong>and</strong> charts covering deal value <strong>and</strong> volumes trend, deal types <strong>and</strong> geographybased<br />
deal activity.<br />
Highlights<br />
This report includes <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong> <strong>Neoprobe</strong> <strong>Corporation</strong>)'s contact information<br />
<strong>and</strong> business summary, tables, graphs, a list of partners <strong>and</strong> targets, a breakdown of financial <strong>and</strong> legal<br />
advisors, deal types, top deals by deal value, detailed deal reports, <strong>and</strong> descriptions <strong>and</strong> contact details of the<br />
partner, target, investor, <strong>and</strong> vendor firms, where disclosed.<br />
The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing,<br />
partnership <strong>and</strong> divestment transactions undertaken by <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong> <strong>Neoprobe</strong><br />
<strong>Corporation</strong>). These deal reports contain information about target company financials, sources of financing,<br />
method of payment, deal values, <strong>and</strong> advisors for various parties, where disclosed.<br />
Reasons to Purchase<br />
<br />
<br />
<br />
Access comprehensive financial deals data along with charts <strong>and</strong> graph covering M&A, private<br />
equity, <strong>and</strong> partnerships <strong>and</strong> alliances.<br />
Form an independent opinion about <strong>Navidea</strong> <strong>Biopharmaceuticals</strong>, <strong>Inc</strong>. (<strong>formerly</strong> <strong>Neoprobe</strong><br />
<strong>Corporation</strong>)s growth strategies through the organic <strong>and</strong> inorganic activities undertaken since<br />
2007.<br />
Track your competitors business structure <strong>and</strong> growth strategies.<br />
Browse complete <strong>Report</strong> on:<br />
http://www.aarkstore.com/business-consumer-services/75523/navidea-biopharmaceuticals-inc-<strong>formerly</strong>-neoprobecorporation-mergers-acquisitions-ma-partnerships-alliances-<strong>and</strong>-investment-report<br />
Table of Content
<strong>Aarkstore</strong> Enterprise<br />
COMPANY OVERVIEW AND KEY FACTS<br />
PARTNERSHIP<br />
--Partnership Overview<br />
--Partnership Deal reports<br />
CAPITAL RAISING<br />
--Capital Raising Overview<br />
--Capital Raising Deal reports<br />
DIVESTMENTS<br />
--Divestments Overview<br />
--Divestments Deal reports<br />
PRIVATE EQUITY & OWNERSHIP<br />
--Private Equity <strong>and</strong> Ownership Overview<br />
--Private Equity <strong>and</strong> Ownership Deal reports<br />
APPENDIX<br />
--About Datamonitor Financial Deals Database<br />
--Deal Definition <strong>and</strong> Methodology<br />
--About Datamonitor<br />
--Datamonitor Professional Services Knowledge Center<br />
List of Tables<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> activity by deal type volume (2010 -YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> legal advisor ranking by value ($m)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> financial advisor ranking by value ($m)<br />
--Top Deals(2010 -YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> targets <strong>and</strong> partners (2010 -YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> partnership volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> partnership trend by key deal type (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> capital raising volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> capital raising by deal type (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> divestments volume <strong>and</strong> value trend (2010-YTD2014)
<strong>Aarkstore</strong> Enterprise<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> divestments activity by geography (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> private equity <strong>and</strong> ownership volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> private equity <strong>and</strong> ownership activity by deal type (2010-YTD2014)<br />
List of Figures<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> activity by deal type - volume (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> partnership volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> partnership trend by key deal type (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> capital raising volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> capital raising by deal type (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> divestments volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> divestments by geography (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> private equity <strong>and</strong> ownership volume <strong>and</strong> value trend (2010-YTD2014)<br />
--<strong>Navidea</strong> <strong>Biopharmaceuticals</strong> private equity <strong>and</strong> ownership by deal type (2010-YTD2014)
<strong>Aarkstore</strong> Enterprise<br />
Related reports:<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Tebodin B.V. - Strategic SWOT Analysis Review<br />
Battelle Memorial Institute - Strategic SWOT Analysis Review<br />
IHS <strong>Inc</strong>. (IHS) - Financial <strong>and</strong> Strategic SWOT Analysis Review<br />
ABM Industries <strong>Inc</strong>orporated (ABM) - Financial <strong>and</strong> Strategic SWOT Analysis Review<br />
G4S Plc (GFS) - Financial <strong>and</strong> Strategic SWOT Analysis Review<br />
Intertek Group plc (ITRK) - Financial <strong>and</strong> Strategic SWOT Analysis Review<br />
McKinsey & Company, <strong>Inc</strong>. - Strategic SWOT Analysis Review<br />
Dow Jones & Company, <strong>Inc</strong>. - Strategic SWOT Analysis Review<br />
RentPath, <strong>Inc</strong>. - Strategic SWOT Analysis Review<br />
Sabre <strong>Corporation</strong> - Strategic SWOT Analysis Review<br />
About <strong>Aarkstore</strong> Enterprise<br />
<strong>Aarkstore</strong> Enterprise is a leading provider of business <strong>and</strong> financial information <strong>and</strong> solutions worldwide. We<br />
specialize in providing online market business information on market research reports, books, magazines,<br />
conference at competitive prices, <strong>and</strong> strive to provide excellent <strong>and</strong> innovative service to our customers.<br />
Contact Details:<br />
<strong>Aarkstore</strong> Enterprise<br />
Phone: +91 998 729 5242<br />
Email: enquiry@aarkstore.com<br />
Our Website: http://www.aarkstore.com
Change language